ДОСВІД ВИКОРИСТАННЯ ПРЕПАРАТУ «ОЛІДЕТРИМ Д3 ФОРТЕ 10 000» В КОМПЛЕКСНІЙ ТЕРАПІЇ ПАЦІЄНТІВ З МЕТАБОЛІЧНИМ СИНДРОМОМ ТА НАЯВНИМ ДЕФІЦИТОМ ВІТАМІНУ D3

Katerina Misiura; Nonna Kravchun; Inna Tykha; Yuri Karachentsev; Oleksandr Kazakov; Olena Dorosh; Anna Cherniaieva; Inna Dunaieva; Iryna Romanova; Pavlo Kravchun

doi:10.21856/j-PEP.2025.1.10

EXPERIENCE IN USING THE DRUG “OLIDETRIM D3 FORTE 10,000” IN THE COMPLEX THERAPY OF PATIENTS WITH METABOLIC SYNDROME AND VITAMIN D DEFICIENCY

Authors

Misiura K. V. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine https://orcid.org/0000-0002-0258-9109
Kravchun N. A. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine; Kharkiv National Medical University, Kharkiv, Ukraine https://orcid.org/0000-0001-7222-8424
Tykha I. A. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine https://orcid.org/0000-0001-6019-7114
Karachentsev Yu. I. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine»; Kharkiv National Medical University, Kharkiv, Ukraine https://orcid.org/0000-0003-1317-6999
Kazakov O. V. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine https://orcid.org/0009-0006-4438-6509
Dorosh O. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine https://orcid.org/0000-0003-4033-282X
Cherniaieva A. O. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine; Kharkiv National Medical University, Kharkiv, Ukraine https://orcid.org/0000-0002-2812-3323
Dunaieva І. П. Kharkiv National Medical University, Kharkiv, Ukraine https://orcid.org/0000-0003-3061-3230
Romanova I. P. SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine
Kravchun P. P. Kharkiv National Medical University, Kharkiv, Ukraine https://orcid.org/0000-0001-7671-1077

DOI:

https://doi.org/10.21856/j-PEP.2025.1.10

Keywords:

vitamin D, metabolic syndrome, Olidetrim, vitamin D deficiency, cardiovascular risk, carbohydrate metabolism, lipid metabolism

Abstract

Objective: to evaluate the effectiveness of “Olidetrim D3 Forte 10,000” in the complex therapy of patients with metabolic syndrome and vitamin D deficiency. The study analyzed the impact of the drug on carbohydrate and lipid metabolism, body weight, blood pressure, and cardiovascular risk. Methods: the study involved 70 patients divided into two groups: the main group (receiving “Olidetrim D3 Forte 10,000”) and the control group (receiving other vitamin D supplements). Dynamic monitoring of 25(OH)D, parathyroid hormone, body mass index, carbohydrate, and lipid metabolism was performed. Results: patients in the main group showed significant improvements in serum 25(OH)D levels, reductions in parathyroid hormone, body weight, and blood pressure, as well as better fasting glucose, glycated hemoglobin, and cholesterol levels. Conclusions: “Olidetrim D3 Forte 10,000” is effective and safe in normalizing vitamin D levels, contributing to reduced metabolic and cardiovascular risk.

Author Biography

Kravchun N. A., SI «V. Danilevsky Institute for Endocrine Pathology Problems of the NAMS of Ukraine», Kharkiv, Ukraine; Kharkiv National Medical University, Kharkiv, Ukraine

² Kharkiv National Medical University, Kharkiv, Ukraine

References

1. Michael F Holick. Rev Endocr Metab Disord 2017;18(2): 153-165. http://doi.org/10.1007/s11154-017-9424-1.

2. Vranić L, Mikolašević I, Milić S. Medicina 2019;55(9): 541. https://doi.org/10.3390/medicina55090541

3. Kostrov MS. Clin Obes Res 2015;16(4): 45-53.

4. Ul'da D, Broud S. Visn Klin Medycyny 2015;30(2): 202-218.

5. Carrelli A, Bucovsky M, Horst R, et al. J Bone Mineral Res 2017;32(2): 237-242. https://doi.org/10.1002/jbmr.2979.

6. Lemieux I, Després JP. Nutrients 2020;12(11): 3501. https://doi.org/10.3390/nu12113501.

7. Lu MC, Chen IJ, Hsu LT, et al. Front Med (Lausanne) 2021;8: 748037. https://doi.org/10.3389/fmed.2021.748037.

8. Komisarenko YuI. Ukr Biochem J 2014;86(1): 111-116. https://doi.org/10.15407/ubj86.01.111.

9. Szymczak-Pajor I, Drzewoski J, Śliwińska A. Int J Mol Sci 2020;21(18): 6644. https://doi.org/10.3390/ijms21186644.

10. Grygor’jeva NV, Tron'ko MD, Kovalenko VM, et al. Konsensus ukrai'ns'kyh ekspertiv 2023;13(2): 60-76. https://doi.org/10.22141/pjs.13.2.2023.368.

11. Takada I, Makishima M. Expert Opin Ther Pat 2015;25(12): 1373-1383. https://doi.org/10.1517/13543776.2015.1093113.

Downloads

Pdf UA (Українська)

Published

2025-03-15

How to Cite

Misiura, K., Kravchun, N., Tykha, I., Karachentsev, Y., Kazakov, O., Dorosh, O., … Kravchun, P. (2025). EXPERIENCE IN USING THE DRUG “OLIDETRIM D3 FORTE 10,000” IN THE COMPLEX THERAPY OF PATIENTS WITH METABOLIC SYNDROME AND VITAMIN D DEFICIENCY. Problems of Endocrine Pathology, 82(1), 89–94. https://doi.org/10.21856/j-PEP.2025.1.10